Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Thoracic Oncology

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/JTO.0000000000000652PMID 26313682PMCID PMC4636439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-small Cell Lung Cancer

  2016cited by this paper
• Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

  2015cited by this paper
• Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement

  2015cited by this paper
• Effect of Ebola Progression in Liberia

  2015cited by this paper
• Modeling the overall survival of patients with advanced‐stage non‐small cell lung cancer using data of routine laboratory tests

  2015cited by this paper
• The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer

  2014cited by this paper
• Development and cross-validation of prognostic models to assess the treatment effect of cisplatin/pemetrexed chemotherapy in lung adenocarcinoma patients

  2014cited by this paper
• Impact of Extratumoral Lymphatic Permeation on Postoperative Survival of Non–Small-Cell Lung Cancer Patients

  2014cited by this paper
• A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer

  2014cited by this paper
• Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist

  2014cited by this paper
• Combining COPD with Clinical, Pathological and Demographic Information Refines Prognosis and Treatment Response Prediction of Non-Small Cell Lung Cancer

  2014cited by this paper
• A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making.

  2014cited by this paper
• Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research

  2013cited by this paper
• Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers

  2013cited by this paper
• A survey of clinical prediction tools in colorectal and lung cancers and melanoma.

  2013cited by this paper
• Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research

  2013cited by this paper
• Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes

  2013cited by this paper
• Prognosis research strategy (PROGRESS) 4: Stratified medicine research

  2013cited by this paper
• Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel.

  2012cited by this paper
• Reporting and Methods in Clinical Prediction Research: A Systematic Review

  2012cited by this paper
• Prognostic Models to Predict Survival in Non–Small-Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab

  2012cited by this paper
• Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia Non–Small-Cell Lung Cancer After Complete Surgical Resection

  2012cited by this paper
• Risk prediction models: II. External validation, model updating, and impact assessment

  2012cited by this paper
• Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker

  2012cited by this paper
• Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325).

  2011cited by this paper
• Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer.

  2011cited by this paper
• Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib

  2011cited by this paper
• The Applicability of a Predictive Index for Second- and Third-Line Treatment of Unselected Non-Small-Cell Lung Cancer Patients

  2011cited by this paper
• Non-small-cell lung cancer.

  2011cited by this paper
• Prediction models in cancer care

  2011cited by this paper
• Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients

  2011cited by this paper
• Combining Clinical, Pathological, and Demographic Factors Refines Prognosis of Lung Cancer: A Population-Based Study

  2011cited by this paper
• Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures

  2010cited by this paper
• Small cell lung cancer

  2010cited by this paper
• Reporting performance of prognostic models in cancer: a review

  2010cited by this paper
• Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.

  2010cited by this paper
• Prognostic Model to Predict Outcomes in Non-Small Cell Lung Cancer Patients with Erlotinib as Salvage Treatment

  2010cited by this paper
• Reporting methods in studies developing prognostic models in cancer: a review

  2010cited by this paper
• Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer

  2010cited by this paper
• The IASLC Lung Cancer Staging Project: Data Elements for the Prospective Project

  2009cited by this paper
• Prognostic model to predict outcomes in nonsmall cell lung cancer patients treated with gefitinib as a salvage treatment

  2009cited by this paper
• A worldwide approach to the TNM staging system: Collaborative efforts of the AJCC and UICC

  2009cited by this paper
• Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.

  2009cited by this paper
• The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer

  2009cited by this paper
• Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model

  2008cited by this paper
• The Impact of Additional Prognostic Factors on Survival and their Relationship with the Anatomical Extent of Disease Expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the Proposals for the 7th Edition

  2008cited by this paper
• A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

  2008cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• Prognostic classification with laboratory parameters or imaging techniques in small-cell lung cancer.

  2007cited by this paper
• 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.

  2006cited by this paper
• Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients.

  2006cited by this paper
• A prognostic model for advanced stage nonsmall cell lung cancer

  2006cited by this paper
• Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors

  2005cited by this paper
• Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data.

  2005cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2005cited by this paper
• A practical prognostic index for inoperable non-small-cell lung cancer

  2005cited by this paper
• The process for continuous improvement of the TNM classification

  2004cited by this paper
• Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis

  2003cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Survival and risk model for stage IB non-small cell lung cancer.

  2002cited by this paper
• TNM: principles, history, and relation to other prognostic factors.

  2001cited by this paper
• Prognostic factors and prognostic staging system for small cell lung cancer.

  1997cited by this paper
• Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer.

  1997cited by this paper
• Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients.

  1997cited by this paper
• What do we need beyond TNM?

  1996cited by this paper
• Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patients

  1987cited by this paper
• Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging.

  1987cited by this paper
• Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung.

  1985cited by this paper
• Small-cell lung cancer.

  1980cited by this paper

• Striving for an Enhanced Tumor Classification System: Reflections on Cancer, Prognosis, Human Nature and Reality

  2025cites this paper
• Identification of prognostic biomarker of non-small cell lung cancer based on mitochondrial permeability transition-driven necrosis-related genes and determination of anti-tumor effect of ARL14

  2025cites this paper
• Discrimination, calibration, and variable importance in statistical and machine learning models for predicting overall survival in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.

  2025cites this paper
• Defining the surgical curative time window: identifying patients with an absence of recurrence for 5 years following surgical resection of stage I invasive non-small cell lung cancer

  2025cites this paper
• Development and Validation of EsoTIME, a Prognostication Tool for Resected Esophageal and Gastroesophageal Cancer

  2025cites this paper
• Clinical and Therapeutic Characteristics of Hospitalized Patients with Advanced Lung Cancer in Najran, Saudi Arabia: A Retrospective Study

  2024cites this paper
• Disease prognosis and therapeutic strategies in patients with advanced non-small cell lung cancer (NSCLC): a 6-year epidemiological study between 2015–2021

  2024cites this paper
• External validation of a novel cancer-associated venous thromboembolism risk assessment score in a safety-net hospital

  2024cites this paper
• Association between renal dysfunction and outcomes of lung cancer: A systematic review and meta‑analysis.

  2024cites this paper
• Predicting 2-year survival in stage I-III non-small cell lung cancer: the development and validation of a scoring system from an Australian cohort

  2022cites this paper
• Biomarker Discovery and Validation: Statistical Considerations.

  2021cites this paper
• Prognostic Factors Determining Survival of Patients Operated for Non-Small Cell Lung Cancer with Consideration Given to Morphological Parameters of Blood

  2021cites this paper
• Clinical utility of prognostic scores and models in decompensated liver disease

  2021cites this paper
• Appraisal of multivariable prognostic models for post-operative liver decompensation following partial hepatectomy: a systematic review.

  2021cites this paper
• Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer

  2021cites this paper
• Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?

  2020cites this paper
• Clone Wars: Quantitatively Understanding Cancer Drug Resistance.

  2020cites this paper
• A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy.

  2020cites this paper
• External validation of a prognostic model for mortality among patients with non–small-cell lung cancer using the Veterans Precision Oncology Data Commons

  2019influential citation
• Personalized prognostication in head and neck cancer: A systematic review of nomograms according to the AJCC precision medicine core (PMC) criteria

  2019cites this paper
• Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer

  2019cites this paper
• Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy.

  2019cites this paper
• Critical appraisal of predictive tools to assess the difficulty of laparoscopic liver resection: a systematic review

  2018cites this paper
• The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma

  2018cites this paper
• Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review

  2018cites this paper
• The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer.

  2018cites this paper
• Decision support systems for incurable non-small cell lung cancer: a systematic review

  2017cites this paper
• Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes

  2017cites this paper
• Risk Models for Individualized Prognosis in the Practice of Precision Oncology

  2017cites this paper
• Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer

  2017cites this paper
• Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.

  2017cites this paper
• An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patients

  2017cites this paper
• The prognosis for prognostic tools

  2017cites this paper
• Staging, Tumor Profile, and Prognostic Groups in Lung Cancer or the New Tower of Babel.

  2016cites this paper
• Akciğer kanserinde 8. TNM sınıflandırmasına doğru

  2016cites this paper
• The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer

  2016cites this paper
• Management of non-small cell lung cancer in the era of personalized medicine.

  2016cites this paper
• Critical Assessment of Clinical Prognostic Tools in Melanoma

  2016cites this paper
• Inhibition of miR-130 a expression promotes metastasis of lung squamous carcinoma cells

  2016cites this paper
• Small cell lung cancer in never-smokers

  2015cites this paper
• E-Cigarette Exposure in Zebrafish Leads to Defects in Neurogenesis Similar to Those Found Following Exposure to Traditional Tobacco Cigarettes

  year unknowncites this paper